Patent office reopens major CRISPR battle between Broad Institute and Univ. of California
The U.S. patent office has declared an interference between a dozen key patents awarded to…
Author: STAT
STAT Plus: The AbbVie and Allergan deal: ‘Two turkeys don’t make an eagle’
Over the past couple of years, AbbVie (ABBV) executives have struggled to convince investors they…
It’s a big week for debates about drug prices, whether pharma likes it or not
D.C. Diagnosis is STAT’s weekly newsletter about the politics and policy of health and medicine….
STAT Plus: Pharmalittle: AbbVie will buy Allergan for $63 billion; Trump administration eyes candidates to run FDA
Hello, everyone, and how are you this morning? We are doing just fine, thank you,…
AbbVie to acquire Allergan for $63 billion in megamerger of pharma giants
AbbVie said Tuesday it will acquire Allergan for $63 billion — the latest megamerger between…
FDA approves controversial women’s libido drug
The Food and Drug Administration approved a controversial drug meant to increase women’s desire for…
VA declines broad coverage for new J&J depression drug touted by Trump
WASHINGTON — A Department of Veterans Affairs committee has declined to approve widespread coverage of…
STAT Plus: ICER says pricing for Novartis MS drug ‘far out of line,’ but more groups push back
A controversial cost-effectiveness watchdog has declared that Novartis (NVS) priced its recently approved multiple sclerosis…
STAT Plus: WHO rescinds opioid guidelines following criticism by two U.S. lawmakers
The World Health Organization has rescinded its opioid-prescribing guidelines after a congressional report accused the agency of…
Listen: A controversial desire drug, courtroom genealogy, & the quest for longer life
Is desire a matter of medicine? Can you convict on genealogy? And what do you…
Pharma CEOs didn’t show up for a congressional scolding, so progressives shadowboxed instead
WASHINGTON — “Is Heather Bresch here?” The mock roll call from Rep. Mark Pocan (D-Wis.)…
Federally funded research drives nearly one-third of U.S. patents, report finds
As researchers bemoan cuts in federal funding for basic science, a new study of millions…
.jpg)
STAT Plus: FDA, accused of being too lax in approval of opioids, outlines new criteria for future approvals
The Food and Drug Administration on Thursday outlined the agency’s plans for weighing submissions for…
A new ‘DNA microscope’ peers deep inside living cells
You could probably find a few biologists who are diehard protein partisans, and others who…
.jpg)
STAT Plus: Drug-pricing watchdog group is ‘mouse that roared’
His adversaries call him a shill for health insurers, a bloodless bean counter who would…
Opinion: You can’t pay for 21st century medicines with a 20th century payment system
Many Americans are angry and worried about the price of prescription drugs. Yet underneath the…
STAT Plus: There’s a fight brewing in Congress over pharma’s patents
D.C. Diagnosis is STAT’s weekly newsletter about the politics and policy of health and medicine….
U.S. preschoolers growing less obese, data show, in latest sign of improvement
CHICAGO — Preschoolers on government food aid have grown a little less obese, a U.S….
STAT Plus: Pharmalittle: Roche hits milestone with personalized cancer drug; data on a fountain of youth drug
Hello, everyone, and how are you today? We are doing just fine, thank you, despite…
STAT Plus: Unity Biotechnology, with big hopes for longevity drugs, shows results highlighting long road ahead
Unity Biotechnology (UBX), a San Francisco biotechnology firm focused on developing drugs that address what…
With eyes on Gilead, lawmakers want details on how HHS reviews possible patent infringement
A pair of lawmakers has asked the Government Accountability Office to review how the U.S….
Opinion: Working together, data scientists and cancer researchers can transform cancer treatment
At a time when data and data science are increasingly essential to improving cancer care,…
Opinion: Hospitals are a missing link in easing the opioid crisis
Nearly half a million individuals with opioid use disorders are hospitalized each year in the…
Amgen, Merck, and Eli Lilly sue over Trump administration policy to require drug prices in TV ads
WASHINGTON — A trio of pharmaceutical manufacturers on Friday filed suit to overturn one of…
STAT Plus: Architects of a new CRISPR partnership defend academic-industry research model
SAN FRANCISCO — With a new deal to use CRISPR to hunt for new drugs,…
After Ebola spills into Uganda, WHO decides against emergency declaration
The long-running and dangerous Ebola outbreak in the Democratic Republic of the Congo — which spilled…
STAT Plus: Up and down the ladder: the latest comings and goings
Hired someone new and exciting? Promoting a rising star? Finally solved that hard-to-fill spot? Share…
STAT Plus: Facing progressive pressure, Pelosi could expand her drug pricing plan to negotiate prices for $118 billion worth of medicines
WASHINGTON — Progressive lawmakers this week exacted a major concession from House Speaker Nancy Pelosi:…
STAT Plus: Pharmalittle: Bluebird Bio prices gene therapy at $1.8 million; lawmakers urge feds to step up generic probe
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: Bluebird’s gene therapy for a rare blood disease will cost $1.8 million. Cue the pricing debate
Bluebird Bio (BLUE) won’t be selling the world’s most expensive drug. The second priciest? Yup….
STAT Plus: As Amazon seeks to win over health care consumers, its PillPack is accused of violating privacy
As Amazon (AMZN) ventures further into health care, the online giant may have to work…
House progressives challenge drug makers to come back to Capitol Hill
WASHINGTON — House progressives on Wednesday called for executives from six drug companies to appear…
STAT Plus: Catalyst sues FDA over rivals’ drug approval, warning it undermines incentives for rare disease meds
The next chapter in an unusual saga involving a high-priced, rare disease drug will play…
Senators want to know if HHS money went to Chinese genomics firms
Two Republican senators are asking whether the Department of Health and Human Services might have…
Health officials ramp up Ebola response after first cases reported in Uganda
This story has been updated throughout. With confirmation that the long-running outbreak in the Democratic…
STAT Plus: Pharmalittle: Florida governor signs importation bill; Oklahoma judge nixes Teva opioid settlement
Hello, everyone, and how are you this fine, sunny morning? The middle of the week…
Opinion: How will we pay for the coming generation of potentially curative gene therapies?
We have arrived at a special moment in health care. Innovative, life-changing gene therapies are…